Mechanisms of Cerebrovascular Events as Assessed by Procoagulant Activity, Cerebral Microemboli, and Platelet Microparticles in Patients With Prosthetic Heart Valves
Author(s) -
Thomas Geiser,
Matthias Sturzenegger,
Urs Genewein,
André Haeberli,
Jürg H. Beer
Publication year - 1998
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.29.9.1770
Subject(s) - medicine , transcranial doppler , platelet , stroke (engine) , pathophysiology , platelet activation , coagulation , cardiology , aspirin , flow cytometry , platelet poor plasma , gastroenterology , anesthesia , surgery , pathology , platelet rich plasma , immunology , mechanical engineering , engineering
Cerebrovascular events (CVE) in patients with prosthetic heart valves (PHV) have remained a severe and frequent complication despite oral anticoagulation with or without aspirin. We studied the possible pathophysiological involvement of platelet-derived microparticles (PMP) as a contributing factor for the increased incidence of CVE in patients with PHV.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom